![Sean Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sean Thompson
Nessuna posizione attualmente
Profilo
Sean Thompson worked as a Director at Variation Biotechnologies (US), Inc. and as a Vice President-Business Development at YM BioSciences, Inc. He also worked as a Manager-Clinical Research at Roche Group and as the Head-Investor Relations at Blackwolf Copper & Gold Ltd.
Thompson received an undergraduate degree from The University of Waterloo.
Precedenti posizioni note di Sean Thompson
Società | Posizione | Fine |
---|---|---|
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Corporate Officer/Principal | 18/08/2010 |
BLACKWOLF COPPER AND GOLD LTD. | Contatto Relazioni con gli Investitori | - |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | - |
Variation Biotechnologies (US), Inc.
![]() Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Formazione di Sean Thompson
The University of Waterloo | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Variation Biotechnologies (US), Inc.
![]() Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
YM BioSciences, Inc.
![]() YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Blackwolf Copper & Gold Ltd.
![]() Blackwolf Copper & Gold Ltd. MiscellaneousMiscellaneous Blackwolf Copper & Gold Ltd. engages in mineral exploration and development. It focuses on its Niblack Project. The company was founded on November 6, 2007 and is headquartered in Vancouver, Canada. | Miscellaneous |
- Borsa valori
- Insiders
- Sean Thompson